Shehnaaz Suliman Alector, Inc. (ALEC) insider trading activity

Shehnaaz Suliman is President and COO of Alector, Inc.. Currently has a direct ownership of 102,598 shares of ALEC, which is worth approximately $176,468. The most recent transaction as insider was on Dec 13, 2021, when has been sold 75,000 shares (Common Stock) at a price of $21.45 per share, resulting in proceeds of $1,608,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K

0% 3M change

0% 12M change

Total Value Held $176,468

SHEHNAAZ SULIMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 13 2021	SELL Open market or private sale	$1,608,750 $21.45 p/Share	75,000 Reduced 42.23%	102,598 Common Stock
Dec 13 2021	BUY Exercise of conversion of derivative security	$1,292,250 $17.23 p/Share	75,000 Added 29.69%	177,598 Common Stock
Dec 10 2021	SELL Open market or private sale	$1,650,750 $22.01 p/Share	75,000 Reduced 42.23%	102,598 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	$1,292,250 $17.23 p/Share	75,000 Added 29.69%	177,598 Common Stock
Dec 09 2021	SELL Open market or private sale	$1,732,500 $23.1 p/Share	75,000 Reduced 42.23%	102,598 Common Stock
Dec 09 2021	BUY Exercise of conversion of derivative security	$1,292,250 $17.23 p/Share	75,000 Added 29.69%	177,598 Common Stock
Dec 08 2021	SELL Open market or private sale	$1,709,250 $22.79 p/Share	75,000 Reduced 42.23%	102,598 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	$1,030,500 $13.74 p/Share	75,000 Added 29.69%	177,598 Common Stock
May 07 2021	BUY Grant, award, or other acquisition	-	100,000 Added 50.0%	100,000 Common Stock

Also insider at

TXG

10x Genomics, Inc. Healthcare

RARE

Ultragenyx Pharmaceutical Inc. Healthcare